Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 44.61
-0.999 %
$ 2.14 B
Market Cap
14.82
P/E
BALANCE SHEET
1.51 B
ASSETS
873 M
LIABILITIES
639 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Amphastar Pharmaceuticals, Inc.
| Current Assets | 490 M |
| Cash & Short-Term Investments | 257 M |
| Receivables | 115 M |
| Other Current Assets | 118 M |
| Non-Current Assets | 1.02 B |
| Long-Term Investments | 15.2 M |
| PP&E | 316 M |
| Other Non-Current Assets | 692 M |
| Current Liabilities | 225 M |
| Accounts Payable | 25.4 M |
| Short-Term Debt | 8.25 M |
| Other Current Liabilities | 192 M |
| Non-Current Liabilities | 648 M |
| Long-Term Debt | 619 M |
| Other Non-Current Liabilities | 28.8 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||
| Cash & Cash Equivalents | 144.3 | 156.1 | 126.4 | 92.6 | 73.7 | 86.3 | 65.6 | 72.4 | 66.1 | 67.8 | 53.6 | 50.2 | |
| Short Term Investments | 112.5 | 19.7 | 10.3 | 13.0 | 11.7 | 2.8 | 2.6 | 0.5 | 1.3 | 1.5 | 0 | 0 | |
| Receivables | 114.9 | 88.8 | 78.8 | 66.0 | 45.4 | 52.2 | 36.0 | 26.8 | 33.2 | 22.9 | 24.6 | 38.3 | |
| Inventory | 105.8 | 103.6 | 92.8 | 96.8 | 110.5 | 69.3 | 63.6 | 79.8 | 70.7 | 82.3 | 69.9 | 51.4 | |
| Other Current Assets | 21.1 | 17.7 | 9.8 | 11.2 | 14.0 | 9.7 | 19.9 | 4.7 | 6.0 | 25.0 | 24.9 | 25.8 | |
| Total Current Assets | 489.6 | 378.3 | 318.1 | 279.7 | 255.2 | 220.3 | 187.8 | 184.1 | 175.9 | 198.0 | 173.0 | 165.7 | |
| PP&E | 315.6 | 264.6 | 271.5 | 280.7 | 253.5 | 210.4 | 185.3 | 152.9 | 142.2 | 138.3 | 116.6 | 107.4 | |
| Intangible Assets | 610.1 | 34.2 | 35.6 | 36.7 | 37.5 | 38.3 | 40.7 | 46.3 | 36.2 | 38.1 | 39.9 | 42.1 | |
| Goodwill | 3.2 | 3.1 | 3.3 | 3.9 | 3.6 | 4.0 | 4.5 | 4.0 | 3.7 | 4.5 | 0.3 | 0.3 | |
| Long Term Investments | 15.2 | 2.4 | 4.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Other Long Term Assets | 25.9 | 20.9 | 16.7 | 5.2 | 11.2 | 9.9 | 8.7 | 9.4 | 4.7 | 3.6 | 2.9 | 2.0 | |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Total Assets | 1 512.9 | 742.0 | 671.5 | 631.2 | 587.0 | 513.6 | 454.7 | 427.7 | 390.1 | 389.4 | 338.7 | 317.5 | |
| LIABILITIES | |||||||||||||
| Accounts Payable | 25.4 | 20.5 | 22.2 | 24.4 | 25.1 | 31.3 | 16.6 | 19.9 | 13.9 | 10.2 | 20.4 | 17.7 | |
| Short Term Debt | 8.2 | 9.1 | 8.2 | 19.0 | 14.1 | 18.2 | 6.3 | 5.4 | 10.9 | 7.6 | 22.1 | 22.1 | |
| Other Current Liabilities | 190.1 | 60.7 | 64.3 | 67.8 | 48.8 | 56.1 | 40.9 | 27.6 | 31.4 | 27.7 | 19.4 | 16.7 | |
| Total Current Liabilities | 225.4 | 94.9 | 103.8 | 112.2 | 90.0 | 106.8 | 67.2 | 60.6 | 60.0 | 62.6 | 65.4 | 60.1 | |
| Long Term Debt | 619.3 | 96.5 | 99.5 | 51.6 | 55.7 | 32.0 | 40.8 | 32.4 | 30.2 | 36.1 | 10.1 | 15.9 | |
| Deferred Tax Income | 0 | 7.4 | 7.1 | 5.5 | 4.3 | 1.4 | 2.2 | 2.3 | 0.5 | 6.3 | 7.2 | 3.2 | |
| Other Liabilities | 28.8 | 21.8 | 22.2 | 17.9 | 12.9 | 9.4 | 7.9 | 4.0 | 3.2 | 5.6 | 2.0 | 1.5 | |
| Total Liabilities | 873.5 | 213.3 | 226.0 | 182.5 | 159.4 | 149.2 | 117.3 | 98.5 | 94.6 | 107.5 | 87.2 | 84.0 | |
| EQUITY | |||||||||||||
| Common Stock | 6 K | 6 K | 6 K | 5 K | 5 K | 5 K | 5 K | 5 K | 5 K | 4 K | 4 K | 4 K | |
| Retained Earnings | 409.3 | 271.7 | 180.3 | 117.8 | 116.4 | 67.5 | 76.2 | 70.9 | 60.3 | 63.1 | 73.8 | 61.9 | |
| Other Accumulative Comprehensive Income/Loss | (8.5) | (8.6) | (6.8) | (3.7) | (4.7) | (4.0) | (2.1) | (4.7) | (2.5) | (1.7) | 0 | 0 | |
| Total Equity | 639.4 | 528.7 | 445.5 | 448.7 | 427.5 | 364.4 | 337.3 | 329.3 | 295.5 | 281.9 | 251.5 | 233.4 | |
| Total Liabilities and Equity | 1 512.9 | 742.0 | 671.5 | 631.2 | 587.0 | 513.6 | 454.7 | 427.7 | 390.1 | 389.4 | 338.7 | 317.5 | |
| SHARES OUTSTANDING | |||||||||||||
| Common Shares Outstanding | 48.3 | 48.6 | 47.8 | 47.0 | 47.0 | 46.4 | 46.1 | 45.4 | 45.0 | 42.0 | 8.0 | 8.0 | 8.0 |